logo
  

Valmont Q2 Net Income Decreases - Quick Facts

Valmont Industries, Inc. (VMI), a leading global provider of engineered products and services for infrastructure and mechanized irrigation equipment for agriculture, reported second quarter net income of $27.9 million compared to $64.0 million, prior year, or $1.19 per share compared to $2.38. Excluding the effects of restructuring, second quarter earnings per share were $1.61.

On average, ten analysts polled by Thomson Reuters expected the company to report profit per share of $1.70 for the quarter. Analysts' estimates typically exclude special items.

Sales were $682.1 million compared to $842.6 million for the same period of 2014. Analysts expected revenue of $734.78 million for the quarter.

"Each of our segments continued to face challenging end-markets. We do not expect the challenges we face in the external environment to abate in the near future," said Mogens Bay, Valmont's Chairman and Chief Executive Officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lincoln Park, New Jersey -based ConSup North America Inc. is recalling around 85,984 pounds of ready-to-eat or RTE sliced prosciutto ham product produced in Germany without the benefit of equivalent inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and...

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT